Quantifying the differences in surgical management of patients with definitive and indeterminate thyroid nodule cytology☆
Introduction
The prevalence of thyroid nodules in the adult population is reportedly up to 50% [1]. This figure is increasing due to the discovery of incidental thyroid nodules on diagnostic imaging for other indications. Although only approximately 5% of clinically significant thyroid nodules are malignant, the incidence of thyroid cancer is also increasing [2,3]. In 2017, thyroid cancer was estimated to be the third most commonly diagnosed cancer among Australian women aged 25–49 years [3].
Fine needle aspiration cytology (FNAC) is a key component of thyroid nodule assessment and malignancy risk stratification, along with clinical assessment and ultrasonography (US). Clinical decision making is relatively straightforward if the FNAC confirms a benign or malignant result. However, in 15–30% of cases the FNAC returns an indeterminate result that carries a risk of malignancy ranging from 5 to 75% [4]. This creates a clinical dilemma for the clinician and patient. Even after repeat cytology, over 20% of these nodules remain indeterminate [5].
The lack of diagnostic certainty affects the clinician's ability to confidently recommend a) surgery, and b) the extent of surgery if deemed necessary – both in terms of the extent of thyroidectomy and the need for central lymph node dissection. While diagnostic hemithyroidectomy is a procedure associated with a low complication rate, it can be a procedure of compromise when it is not the definitive surgery required for a given pathology. However, it is also important to recognise that the decision for surgery or extent of surgery does not solely rest on the malignancy status of the nodule, but also the overall symptomatology and other factors.
In recent years, adjuncts to cytology such as mutation testing have been developed and continue to be refined. While some investigators have reported promising results, their clinical utility is not uniformly demonstrated, and they are not readily available outside the United States [6]. Therefore, this study aimed to 1) quantify the potential room for improvement in clinical decision making with improved pre-operative diagnosis of thyroid nodules, taking into account other non-malignancy related indications for surgery; and 2) investigate if clinical factors can further improve the pre-operative diagnostic accuracy of thyroid nodules without definitive cytology.
Section snippets
Materials and Methods
This is a case-control study from the Monash University Endocrine Surgery Unit (MUESU). Prospectively collected clinical data on patients undergoing thyroidectomy over a 15-year period from 2001 to 2015 was used for the analysis. The 2015 cut-off was chosen to minimise the effect of updated recommendations on the treatment of low risk papillary thyroid cancers [7]. The study group comprised of all patients who had fine needle aspiration cytology (FNAC) of a thyroid nodule with corresponding
Results
A total of 3821 cases with complete data were included in the analysis. Of these, 2582 (68%) cases were included in the DC group, and 1239 (32%) cases were in the IC group. Another 1732 cases were excluded due to incomplete data (N = 1474), previous thyroid surgery (N = 210) or lymph node dissection only (N = 48).
Discussion
The clinical impact of the lack of a definitive cytological diagnosis in patients with thyroid nodules is demonstrated in the findings of this study. Patients without a definitive cytological diagnosis pre-operatively were more likely to have a hemithyroidectomy as their primary procedure. Given the low complication rate, hemithyroidectomy per se is not a problem. However, this study also found that significantly more patients with indeterminate cytology required a completion thyroidectomy, and
Declaration of competing interest
There is no conflict of interest to declare.
Acknowledgements
We acknowledge the contribution of our multidisciplinary colleagues for the clinical care of the patients, and Dr M Yeung and A/Prof W Johnson for contribution of cases to the MUESU database. We would also like to thank our former database manager Ms Melissa Vereker for populating and maintaining the database.
References (32)
- et al.
The epidemiology of thyroid disease and implications for screening
Endocrinol Metab Clin N Am
(1997) - et al.
Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology
Surgery
(2012) - et al.
Gauging the extent of thyroidectomy for indeterminate thyroid nodules: an oncologic perspective
Endocr Pract
(2017) - et al.
Controversies in primary treatment of low-risk papillary thyroid cancer
Lancet
(2013) - et al.
Differential recurrent laryngeal nerve palsy rates after thyroidectomy
Surgery
(2014) - et al.
Thyroid cancer surgery guidelines in an era of de-escalation
Eur J Surg Oncol
(2018) - et al.
Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis
Endocrine
(2013) Cancer in Australia 2017
Cancer Series No. 101. Cat. No. CAN 100
(2017)- et al.
Preoperative diagnosis of benign thyroid nodules with intermediate cytology
Gland Surg
(2012) - et al.
Evaluation of the effect of diagnostic molecular testing on the surgical decision-making process for patients with thyroid nodules
JAMA Otolaryngol Head Neck Surg
(2016)
American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer
Thyroid
The impact of synoptic cytology reporting on fine-needle aspiration cytology of thyroid nodules
ANZ J Surg
Thyroid ultrasound-guided fine-needle aspiration cytology results: observed increase in indeterminate rate over the past decade
Otolaryngol Head Neck Surg
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology
N Engl J Med
A large multicenter correlation study of thyroid nodule cytopathology and histopathology
Thyroid
The Bethesda system for reporting thyroid cytopathology: a meta-analysis
Acta Cytol
Cited by (17)
A multi-channel deep convolutional neural network for multi-classifying thyroid diseases
2022, Computers in Biology and MedicineDeep convolutional neural networks in thyroid disease detection: A multi-classification comparison by ultrasonography and computed tomography
2022, Computer Methods and Programs in BiomedicineCitation Excerpt :Besides, clinical assessment and interpretation of results experienced with thyroid conditions are crucial. Despite technological advances over the last century, the risk of over- or under-treatment remains a reality in thyroidology [1]. Streamlining this process has the potential to confer a significant clinical advantage, considering the increasing prevalence of thyroid diseases worldwide, especially malignancies [2].
Ultrasound imaging in thyroid nodule diagnosis, therapy, and follow-up: Current status and future trends
2023, Journal of Clinical Ultrasound
- ☆
Part of this study was presented by YJL at the Royal Australian College of Surgeons Annual Scientific Congress in 2015 & other parts were presented by RS in 2018. JCL was the recipient of the Royal Australasian College of Surgeons Senior Lecturer Fellowship in 2017 and 2018.